Investing

Sarissa Capital Management chief investment officer Alex Denner spoke with CNBC Pro for an exclusive interview from the Delivering Alpha Conference in New York, and detailed his case for investing in Biogen. Like other shareholder activists, Denner’s approach focuses on improving the strategies of companies to unlock otherwise trapped equity value. Having previously served as
0 Comments
President Donald Trump‘s criticism of monetary policy won’t have much impact on how the Federal Reserve goes about its business, judging by initial market reaction. While making for more eye-popping headlines out of the Oval Office, the president’s complaints that rising interest rates are hampering economic progress did not move the fed funds futures market,
0 Comments
Low costs are likely how JPMorgan hopes to attract assets into both BBJP and BBEU, which, as vanilla, market-cap weighted equity ETFs, look very similar to existing products. BBJP’s portfolio looks almost identical to the bigger, older EWJ, even though BBJP pulls from stocks listed on either the Tokyo and Nagoya Stock Exchanges, whereas EWJ
0 Comments
Getty Images Workers pack and ship customer orders at the 750,000-square-foot Amazon fulfillment center in Romeoville, Illinois. Amazon shares will surge this year due to its expansion into new industries and countries, according to Deutsche Bank. The firm raised its price target to $2,200 from $1,800 for Amazon shares, representing 21 percent upside to Thursday’s
0 Comments
Alphabet’s internet search and advertising businesses are thriving, according to Goldman Sachs. The firm raised its price target to $1,350 from $1,250 for Alphabet shares, representing 11 percent upside to Wednesday’s close. Goldman also reiterated its buy and conviction list rating for the company. “Our advertiser checks point to a solid 2Q, with particular strength
0 Comments
Amid a big year in markets for cannabis companies, Canadian medical marijuana company Tilray made its debut on the Nasdaq on Thursday — becoming the first pure-play marijuana company to go public on a major U.S. exchange. And Tilray President and CEO Brendan Kennedy told CNBC that the buzz around cannabis is only going to
0 Comments
Alex Roepers of Atlantic Investment Management recommended Huntsman Corp. as his best idea Wednesday during the Delivering Alpha conference. The Woodlands, Texas-based company is a manufacturer of differentiated organic chemical products and of inorganic chemical products. Shares jumped on his recommendation and were most recently up nearly 2.5 percent after rising 4 percent earlier. Roepers
0 Comments
Purchase, New York-based Greenhaven invests with a three- to four-year time horizon and manages approximately $7.5 billion for wealthy families, university endowments and nonprofits. From 1988–2017, the average annual return of a Greenhaven portfolio had been roughly 19 percent (before fees). Wachenheim, who also founded the management company, argued that Citi’s success in its corporate
0 Comments
“If we’re less than 3 percent away, we could get there by the end of the month, if not the end of the week,” said Samuel Stovall, chief investment strategist at CFRA. Midterm election years typically have a rough period midyear, then stocks often finish up with a rally after the election. But the fact
0 Comments
Big banks continue to be a profitable group despite being immensely disliked on the Wall Street, CNBC’s Jim Cramer said Monday. “I think this group is hated,” Cramer said on “Squawk Box,” shortly after Bank of America reported better-than-expected second quarter earnings. “More hated than I’ve seen than any other time other than 2009 and
0 Comments
Chris Brightman of Research Affiliates says a simple equal-weighted strategy can do even better when combined with regular rebalancing. Rebalancing is essentially trimming stocks that have outperformed and buying those that have underperformed given a historical tendency for prices to revert to an average. In essence, Brightman added, it’s betting against the current Wall Street
0 Comments